Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

FDA expands eligibility for Pfizer Covid booster shots to 16- and 17-year-olds amid omicron fears

by
December 9, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Fed sees interest rate hikes continuing until inflation eases substantially, minutes show

The Average 401(k) Balance by Age

A 16-year-old teenager, receives a dose of the Pfizer-BioNtech COVID-19 coronavirus vaccine.

Jack Guez | AFP | Getty Images

The Food and Drug Administration on Thursday expanded eligibility for Pfizer and BioNTech’s booster shot to people who are 16 and 17 years old at least six months after their primary vaccination.

The FDA’s emergency authorization comes a day after Pfizer and BioNTech released initial lab data indicating that booster shots provide high levels of protection against the highly mutated omicron variant of the virus that causes Covid-19.

The preliminary data found that omicron significantly reduces the protection provided by the initial two-dose series. Boosters, on the other hand, fight the variant at levels comparable to the 95% protection provided by the two-dose series against the original strain of the virus, the lab results showed.

“As people gather indoors with family and friends for the holidays, we can’t let up on all the preventive public health measures that we have been taking during the pandemic,” acting FDA Commissioner Janet Woodcock said in a press release. “With both the delta and omicron variants continuing to spread, vaccination remains the best protection against COVID-19.”

The Centers for Disease Control and Prevention still needs to authorize boosters for 16- and 17-year-olds before the shots are administered. The CDC cleared booster shots for all adults 18 and over last month.

Public health authorities in the U.S. are calling for everyone who is eligible to get a booster shot, amid fears of a winter Covid surge driven by the delta variant and uncertainty about the future course of the pandemic due to omicron.

The efficacy of the initial two-dose vaccination series was declining before the arrival of omicron.

This is breaking news. Please check back for updates.

ShareTweetPin

Related Posts

Fed sees interest rate hikes continuing until inflation eases substantially, minutes show

by
August 17, 2022
0

Federal Reserve officials at their July meeting indicated they likely would not consider pulling back on interest rate hikes until...

The Average 401(k) Balance by Age

by
August 17, 2022
0

Proper Planning for Retirement Your financial objectives and investment goals relate to you and your family alone. The steps you...

FOMC Minutes "Participants anticipated that this slowdown in housing activity would continue"

by
August 17, 2022
0

by Calculated Risk on 8/17/2022 02:10:00 PM From the Fed: Minutes of the Federal Open Market Committee, July 26-27, 2022....

Monkeypox cases jumped 20% in the last week to 35,000 across 92 countries, WHO says

by
August 17, 2022
0

Residents wait in line at a DC Health location administering the monkeypox vaccine on August 5, 2022 in Washington, DC....

Frenzied trading in meme stocks is a warning sign for the broader market

by
August 17, 2022
0

Feverish trading in speculative stocks can be a warning sign that the broader market is near a top. Bed Bath...

Next Post

Fed's Flow of Funds: Household Net Worth Increased $2.4 Trillion in Q3

EPA lowers ethanol requirements, citing reduced demand

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net